Full coverage: Insolvency

Creditors, including companies in Australia and Belize, have appointed a liquidator to Leveris, an Irish fintech that was once valued at €190m. Documents reveal who was owed money and how much they lost.

Joe Walsh Tours was one of Ireland’s oldest travel agents and tour operators. However, board minutes, legal filings and correspondence with the regulator reveal just what went wrong, and who is owed what. They also shed light on the company’s battle to survive a pandemic.

Those who lost their jobs when the retailer’s Irish stores went into liquidation one year ago were promised enhanced redundancy, but existing rules means there is no money to pay it. How will the stand-off end?

Yesterday morning, KPMG accountant Kieran Wallace finalised a 246-page document detailing how Norwegian Air can be saved from collapse. Obtained by The Currency, the scheme of arrangement gives the inside story of what went wrong, and the new turnaround plan.

Experienced businessman Peter O’Donoghue steps down from Dublin confectionery maker to avoid a conflict of interest. It marks the latest twist in Broderick’s saga.

Assets including a high-profile property in south Co Dublin were at the centre of a multi-million legal battle between the state's bankruptcy trustee and businessman Alistair Tidey – until the dispute was settled out of court.

Patrick McCormack, the former boss of the McCauley pharmacy chain, is leading the consortium to buy Ramona Nicholas’s Cara chain from insolvency. Here, we reveal how much money is being invested, how much is being written down and the future plans for the chain.

In September, Ramona McNicholas’s chain of chemists went into examinership as creditors bayed for €3.7 million. Now another pharmacist turned businessman is getting ready to take her place.

A minority family shareholder was accused in the High Court of going on a “wrecking mission” as Broderick's main stakeholder positioned itself as a steady hand on the tiller.

Ramona Nicholas and her husband Canice wanted to build an international chain of 100 pharmacies. Instead, confidential documents reveal the true scale of the company’s financial woes, including a history of losses, debt, and creditor default. Can it now be saved?